Vineet R. Jindal founded Stockr, Inc. and Bay Street Advisors, Inc. Presently, he holds the position of Chief Financial Officer for Reneo Pharmaceuticals, Inc.
Mr. Jindal previously held the position of Chief Executive Officer & Director at Stockr, Inc., Vice President-Corporate Communications & Strategy at Reata Pharmaceuticals, Inc., Chief Business Officer at Caliber Corporate Advisers LLC, President, Chief Executive Officer & Director at Viper Gold Ltd., President, Chief Executive Officer & Director at QuikFlo Health, Inc., Principal at Boston Millennia Partners, Analyst at Wedbush Securities, Inc. and Principal at ThinkEquity Partners.
Vineet R. Jindal received a graduate degree from Cornell University and an undergraduate degree and a graduate degree from the University of California, Berkeley.
What is Vineet R. Jindal's net worth?
The estimated net worth of Vineet R. Jindal is at least $8,400.00 as of August 25th, 2021. Mr. Jindal owns 5,000 shares of Reneo Pharmaceuticals stock worth more than $8,400 as of April 24th. This net worth estimate does not reflect any other investments that Mr. Jindal may own. Learn More about Vineet R. Jindal's net worth.
How do I contact Vineet R. Jindal?
Has Vineet R. Jindal been buying or selling shares of Reneo Pharmaceuticals?
Vineet R. Jindal has not been actively trading shares of Reneo Pharmaceuticals in the last ninety days. Most recently, on Wednesday, August 25th, Vineet R. Jindal bought 5,000 shares of Reneo Pharmaceuticals stock. The stock was acquired at an average cost of $7.44 per share, with a total value of $37,200.00. Following the completion of the transaction, the chief financial officer now directly owns 5,000 shares of the company's stock, valued at $37,200. Learn More on Vineet R. Jindal's trading history.
Who are Reneo Pharmaceuticals' active insiders?
Are insiders buying or selling shares of Reneo Pharmaceuticals?
In the last twelve months, Reneo Pharmaceuticals insiders bought shares 1 times. They purchased a total of 125,000 shares worth more than $1,000,000.00. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 115,625 shares worth more than $808,125.00. The most recent insider tranaction occured on August, 28th when insider Ashley Hall sold 15,625 shares worth more than $98,125.00. Insiders at Reneo Pharmaceuticals own 17.9% of the company.
Learn More about insider trades at Reneo Pharmaceuticals. Information on this page was last updated on 8/28/2023.
